This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Irinotecan worth it in colorectal cancer. Pharmacoecon. Outcomes News 260, 9 (2000). https://doi.org/10.1007/BF03275443
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275443